|
| | Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]- Basic information |
| | Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]- Chemical Properties |
| Boiling point | 1466.3±65.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | solubility | Methanol (Slightly), Water (Slightly) | | form | Solid | | pka | 9.86±0.26(Predicted) | | color | Off-White to Pale Yellow | | Stability: | Hygroscopic |
| | Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]- Usage And Synthesis |
| Uses | Des-(5-(threo-3-hydroxy-L-ornithine)) Caspofungin Acetate is an intermediate in the preparation of Caspofungin. It is the impurity of Caspofungin Acetate (C184900), an echinocandin that inhibits the synthesis of β (1,3)-D-glucan, an integral component of the fungal cell wall. An antifungal drug used in the treatment of invasive fungal infections. |
| | Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]- Preparation Products And Raw materials |
|